May 15, 2019, 08:18 pm

AbbVie, Boehringer Settle Humira Patent Dispute in U.S.

 15-05-2019 8:18 PM

Under the agreement, Boehringer will to pay AbbVie royalties for licensing its Humira patents and agreed to acknowledges the validity and enforceability of the patents, AbbVie said.

Posted in: Tags:
Delaware Business Court Insider
Delaware Business Court Insider

This article was posted online by Delaware Business Court Insider. Spot On Delaware collects excepts of news articles from this news source and add these in the 'Delaware Business'-category. For mor einformation about Spot On Delaware, you can check the About Us-page.

This story was posted in the category: